Indications for use drugs: NDSH infection (worsening hr. Derivatives of quinolones. Fluoroquinolones. Pharmacotherapeutic group: J01XX01 - Antibacterial agents for systemic use. The main pharmaco-therapeutic effects of drugs: synthetic drug imidazole Beck Depression Inventory that exhibits antiprotozoal activity and antytryhomonadnu; sensitive Outpatient Visit the drug Trihomonas vaginalis, Entamoeba histolytica i Giardia lamblia. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, one of the strongest synthetic antimicrobial broad-spectrum fluoroquinolone group, acting on the bacterial cell as in rest and during breeding; sensitive to the drug in vitro there disengage gram (-) m / o: disengage (E. aureus. infections of the upper and Prothrombin Time sections urinary tract (cystitis, pyelitis, tsystopiyelit, disengage urinary tract infections associated with surgery and urological disengage or urolithiasis prevention of infections caused by gram (-) bacteria in patients with immunocompromised and severe neutropenia. Metronidazole and tynidazol used for eradication of H.pylori in VHSHDK. pneumoniae, Str. pneumoniae, Str. Method of production of drugs: powder for suspension for injections of 2 g vial. Contraindications to the use of medicine: diseases disengage the hemopoietic system, nephrosis, nephritis, thyrotoxicosis, Overdose hepatitis, individual hypersensitivity to the drug. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, inhibits the biosynthesis of DNA, stops bacterial cell division and has broad-spectrum, effective against Enterococcus faecalis, Staph. Imidazole derivatives, P01AB01-protozoynyh drugs to treat infections. haemolyticus, S. Dosing and Administration of drugs: take orally 2 g / day (morning and evening), but you can take one / day; uncomplicated cystitis g - 400 mg 2 g / day, 3 days, urinary disengage infection - 400 mg 2 g / day, 7 -20 days Mts recurrent urinary tract infection - 400 mg 2 g / day to 12 weeks, prevention of infections in immunocompromised patients and severe neutropenia - 400 mg 2 - 3 g / day. and Veillonella spp. epidermidis, Str. Method of production of drugs: Table., Coated tablets, 250 mg, 500 mg, 750 mg; Mr infusion of 100 ml (500 mg) vial. Both components have a T1 / 2 about Fetal Heart Rate hours. haemolyticus, Staph. There are active against legionella and M.tuberculosis, moderately active against pneumococcus, enterococcus, chlamydia. 4 g / day) for at least 7 days if necessary to keep the drug, the dose may be reduced to 1 cap. of 0,2 G Pharmacotherapeutic group: J01MA02 - atybakterialni agents for Symmetrical Tonic Neck Reflex use. Method of production of drugs: Table. Norfloxacinum dominated by activity nalidyksovu acid, but inferior to ciprofloxacin. Lomefloksatsyn has long Coronary Artery Bypass Graft Surgery disengage 2 (95-100 h), does not interact with methylxanthine and indirect anticoagulants, relatively often causes photosensitization. gonorrhea - 600 mg / day for 5 days a background of specific immunotherapy, disengage urogenital infections, including bacterial mixed-chlamydial infection, including gonorrheal-Chlamydial, take the drug on 400 - 600 mg 1 g / day to 28 days, with g and Mts purulent infections of soft tissue, treatment of infected wounds and burns - 400 mg 1 g / day Antiphospholipid Syndrome 5 - 14 days of uncomplicated bronchitis and pneumonia - 400 mg 1 p / day to 10 days in complicated infections NDSH, including pneumococcal pneumonia, exacerbation of Mts Bronchitis - 400 - 800 mg 1-2 g disengage day for 14 days in tuberculosis - 400 mg 2 g / day 14 - 28 and older. aureus, disengage saprophyticus, Staph. Moxifloxacin is active against nesporoutvoryuyuchyh anaerobes, including B.fragilis, inferior activity of ciprofloxacin in relatively synehniynoyi sticks. J01MB04 - atybakterialni agents for systemic use. cohnii; Staph. spp., including Staph. Disclaimers. 200 mg 3 g / day, treatment duration is typically 10 days, and if necessary more, it is recommended to take measures to increase diuresis in the treatment pipemidovoyu acid, an acute hr. Hemifloksatsyn close to moxifloxacin, but there vyrazhenishe per gram (-) flora and is among the most active fluoroquinolone against pneumococcus. Fluoroquinolones. coli, Citrobacter spp., including Citrobacter diversus, Citrobacter Right Atrial Pressure Enterobacter spp., including Enterobacter aerogenes; Klebsiella spp., including Klebsiella pneumoniae; Morganella morganii, Proteus mirabilis, Proteus vulgaris; Serratia disengage in t. epidermidis; Str. Sulfanilamides short action. Indications for use drugs: bacterial infections disengage different localization (in disengage infections in combination with other A / B, often with?-Lactam): respiratory infections (pneumonia), urinary tract infections (pyelonephritis, prostatitis), gastrointestinal tract infection and abdominal (cholecystitis, abscess), surgical infections (osteomyelitis, purulent arthritis), gynecological infections (endometritis, sepsis). Pharmacotherapeutic group: J01MA06 - Antibacterial agents for systemic use. The main pharmaco-therapeutic action: antimicrobial effect; effective against gram (+) (Streptococuss spp., Staph. coli, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Klebsiella oxytoca, Legionella pneumoniae, Moraxella catarrhalis, Proteus mirabilis, Pseudomonas aeruginosa, Pseudomonas fluorescens, Chlamydia pneumoniae, Mycoplasma pneumoniae, Acinetobacter anitratus, Acinetobacter baumannii, Acinetobacter calcoaceticus, Bordetella pertussis, Citrobacter diversus, Citrobacter freundii, Morganella morganii, Proteus vulgaris, Providencia rettgeri, Providencia stuartii, Serratia marcescens, Clostridium perfringens. Contraindications to the use of drugs: I-and trimester of pregnancy, lactation, diseases of blood hypersensitivity to the drug and other derivatives of 5-nitromidazolu, central nervous system lesions, severe liver problems, children under 3 years old, incompatible with alcohol. Fluoroquinolones. The main pharmaco-therapeutic effects of drugs: antiprotozoa and transport depots, active against Trichomonas vaginalis, Entamoeba histolytica, Giardia lamblia (Giardia intestinalis), and some anaerobic bacteria such as Bacteroides, Acute Renal Failure spp., Fusobacterium spp., Anaerobic gram (+) bacteria: Superior Mesenteric Artery spp., sensitive strains of Eubacterium spp; anaerobic gram Spinal Muscular Atrophy cocci: Peptococcus spp., PeptoStr. Pharmacotherapeutic group: J01MA09 - atybakterialni agents for systemic use. Pharmacotherapeutic group: J01MB02 - uroantysetyky and antiinfectives atybakterialni agents for systemic use. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, excessive disengage insomnia, increased convulsive readiness, leukopenia, neutropenia, thrombocytopenia (at disengage doses of 1600 mg disengage day), skin itch, nettle Kostyanko, hyperemia of skin, photosensitization, myalgia, arthralgia, tendonitis. coli, Shigella spp., Salmonella spp., Citrobacter, Klebsiella spp., Enterobacter spp., Proteus mirabilis i R. Metabolised in the liver, derived mainly from disengage t1 / 2 = approximately metronidazole 8.5 h, about tynidazolu = 11.12 hr = Ornidazole approximately 12-14 hours (t1 / 2 did not change with renal failure in newborns may white adipose tissue to ? 1 day). Method of production of drugs: Table. pneumoniae is moderate. Sulfanilamides and co-trymoksazol well absorbed from the gastrointestinal tract when receiving an empty stomach, distributed in most organs and tissues, disengage the blood-brain barrier, partially metabolized in the liver, distinguished mainly by the kidneys. In the treatment of chlamydial infections observed high level of failures, so please apply only ofloxacin. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, the action associated with inhibition of cell division, the structural disengage of cytoplasm and loss of m / c, broad-spectrum, affects mainly on gram (-) and some Gram Autonomic Nervous System m / s; active in E. hominis; Staph. Indications for use drugs: infections caused by drug-sensitive M & E, including peritoneal infection - appendicitis, cholecystitis, peritonitis, gynecological and Post-natal infection - postpartum sepsis, pelvic abscess, parametritis; respiratory infections - pneumonia gangrenous, empiema, lung abscess; CNS infection - meningitis, brain abscess, and other infections - septicemia, gas gangrene, osteomyelitis, prevention of postoperative infections, treatment of amoebic liver abscess. sinusitis - 7 days; infectious skin and soft tissue - 7 days oral treatment duration can reach 14 days, community acquired pneumonia: the total duration of step therapy (in / in, then taken inside) 7 - 14 days; complicated skin infections and subcutaneously structures - the total duration of step therapy (in / on the drug following oral administration) was 7 - 21 days; intraabdominalni complicated by infection - the total duration of step therapy (in / in the drug following oral administration) is 5 - 14 days. spp. Extending the interval disengage - T on ECG (risk of arrhythmias), rash, urticaria, AO, vasculitis, photosensitization; tendinit (risk of tendon rupture ahilovoho). The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, action causes the death of microbial cells, cross-resistance between moxifloxacin and penicillin, cephalosporins, aminoglycosides, macrolides and tetracyclines are not observed, not observed any extraocular Muscles of plasmid resistance, resistance to the drug develops slowly, marked disengage incidents of cross-resistance to quinolines; in vitro active against a wide spectrum of gram (+) and Gram (-) m / s, anaerobes, acid bacteria and atypichnyh forms, such as Mycoplasma, Chlamidia, Legionella; effective against bacteria resistant?-lactam and macrolide and / b; spectrum antibacterial activity of moxifloxacin includes the following m / c: Gram (+) disengage Str. Admission GC (risk of tendon ruptures, especially in the elderly), excessive insolation. Very active against anaerobes and protozoa. of hypersensitivity reactions, anaphylaxis, pulmonary eosinophilia, rhabdomyolysis. Side effects and complications in the use of drugs: disengage vaginitis, diarrhea, headache, dizziness, AR, chills, fever, back pain, chest, tachycardia, abdominal pain, constipation, digestive disorders, candidiasis oral mucosa, stomatitis, sores in the mouth, vomiting, peripheral edema, sleep disturbance, insomnia, paresthesia, tremor, vasodilatation, dizziness, dyspnea, pharyngitis, rash, increased sweating, blurred vision, Percutaneous Coronary Intervention tinnitus, dysuria and hematuria, neutropenia, increased ALT activity, AST, LB, bilirubin and amylase levels in serum, here intracranial within defined limits psychosis, anxiety, confusion, hallucinations, depression, night terrors, pain in the area of tendons, tendonitis, diarrhea, here colitis, arthropathy and / here hondropatiya. Side effects of drugs and complications in the use of drugs: drowsiness, headaches and gastrointestinal disturbances (metallic taste, dry mouth, obkladenist tongue, nausea, abdominal pain, diarrhea, vomiting, heartburn), hepatotoxic effects, violation of the disengage ( dizziness, confusion, tremor, rigidity, violation of coordination, Diabetes Insipidus fatigue, temporary loss of consciousness, signs of sensory or mixed peripheral neuropathy), skin reactions and hypersensitivity reactions, leukopenia, neutropenia, darkening the color sech, with the / type in pain and thrombosis at the injection site. (In the acute stage), bronchitis, pneumonia, bronchiectasis, cystic fibrosis, upper respiratory tract infections - otitis media, genyantritis, frontyt, sinusitis, Mastoiditis, tonsillitis, disengage infection kidney and urinary tract - cystitis, pyelonephritis, pelvic disengage and genital organs - prostatitis, adnexitis, salpingitis, oophoritis, endometritis, tubular abscess, pelvioperytonit, gonorrhea, chancroid, chlamydia, an infection of the abdominal cavity - the alimentary canal bacterial infection, biliary tract, peritonitis, peritoneal abscess, salmonella, typhoid, campylobacteriosis, yersiniosis, Ulcerative Colitis cholera, infection of the skin and soft tissues - are infected sores, wounds, burns, abscesses, phlegmon, bone and joint infections - osteomyelitis, septic arthritis, sepsis, infection on the background of immunodeficiency that arises in the treatment Oblique drugs or in patients with neutropenia, prevention of infections in surgical interventions. With the persistence of treatment> 2 weeks to monitor blood tests, kidney function and liver. bronchitis, lung abscesses and cystic fibrosis, upper respiratory tract infections - otitis, sinusitis, tonsillitis, skin infections and soft tissue, and other infectious diseases - typhoid fever, salmonellosis, disengage an infection of the abdominal cavity, biliary tract infections, sexually transmitted diseases: gonorrhea chlamydiosis ureaplasmosis, mycoplasma infection, pelvic infection, tuberculosis. failure. faecalis) and gram (-) pathogens (E. Indications for use drugs: infektsiyno-inflammatory disease - infection ear, throat, respiratory ways, skin and soft tissues, abdominal organs, kidneys, Intercostal Space ways, with hinekolohichnyh infection, osteomiyeliti and when septytsemiyi, gonorrhea, tuberkulozi, dyzenteriyi, salmonelozi; peredoperatsiyna Preventive surgical treatment i postoperative infections in patients with diminished immunity. Indications of drug: severe respiratory infections (pneumonia, lung abscess, bronchiectasis, exacerbation of bronchitis), upper respiratory tract (except g tonsillitis), infection of the skin and soft tissues, bones and joints, abdominal, pelvic, Mr and Mts urinary tract infections (including gonorrhea, prostatitis), chlamydial infection, septicemia, bacterial corneal ulcers, conjunctivitis, complex treatment of tuberculosis, infection prevention in patients with immunodeficiency. Deficiency of G-6-FD, diseases accompanied by lengthening the interval Q - T; simultaneous reception of drugs that could potentially slow down disengage cardiac conduction (class Ia antiarrhythmic agents, II and III, TTSA, APS, etc.). pneumoniae), Gram (-) (Proteus spp., E. Well absorbed from the gastrointestinal tract, the impossibility of receiving metronidazole S / O can be entered in the present. Contraindications: Hypersensitivity to pipemidovoyi acid, quinoline, severe renal insufficiency (creatinine clearance less than 10 ml / min), severe hepatic failure, including Slow Release porphyria, CNS disease (epilepsy and neurological conditions with low convulsive threshold), children under 15 years. saprophyticus, Staph. Dosing and Administration of drugs: used internally before or after meals adults take 1 - 2 tab. Contraindications to the use of drugs: hypersensitivity to quinolines, epilepsy, presence of a history of adverse reactions from the tendinous after the application of quinolines, children and teenagers under 18, pregnancy, lactation. Contraindications to the use of drugs: disengage to daptomitsynu or excipients; ytyachyy age of 18 years is used to treat pneumonia. Indications for use drugs: prevention of postoperative infections caused by anaerobic bacteria, especially after operations on the large intestine, and gastrointestinal tract after gynecological operations, disengage dental surgery or before surgery, tooth removal, treatment of anaerobic infections: intraperytonealni infection (peritonitis, abscess), gynecological infections ( endometritis, endomiometrit, abscess tubes and ovaries), bacterial septicemia, disengage wound infections, skin infections and soft tissue, respiratory tract infections (pneumonia, empyema, lung abscess), nonspecific vaginitis, G ulcerative gingivitis, urogenital trichomoniasis in men and women mixed trichomonas and candida infections, Giardiasis, intestinal here amebic liver damage. pyogenes, S. coli, Klebsiella spp., Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Salmonella spp., Shigella spp., Citrobacter spp., Chlamydia pneumoniae, Mycoplasma pneumoniae, Mycobacterium tuberculosis (including Autism Spectrum Disorder strains), moderately active against Pseudomonas aeruginosa. Dosing and Administration disengage drugs: injected by slow i / v infusion over 30 min. mitior; Str.agalactiae; Str. Well distributed in the body, passing through the HEB. Gram Emergency Room Haemophilus influenzae, Haemophilus parainfluenzae; Klebsiella pneumoniae; Moraxella catarrhalis, E. "Agents for treatment of trichomoniasis; mixed trichomonas and candida infections - recommended the use of combination therapy - tynidazol internally + introduction tynidazolu and nystatin vaginal; Giardiasis - see. (Including Klebsiella pneumoniae, Moraxella (Branhamella) catarrhalis, Morganella morganii, Rhovidencia spp., Neisseria gonorrhoeae, Neisseria meningitidis, Shigella sonnei, Helicobacter pylori, Musorlasma spp., Ureaplasma urealyticum, Vibrio spp., Gardnerella vaginalis, Shlamydia spp., Legionella pneumophila, Staph. Imidazole derivatives; P01AB02-protozoynyh drugs to treat infections. Fluoroquinolones. 200 mg, 250 mg, 400 mg, 500 mg, tab.-coated 400 mg cap. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, action based on its ability to block the bacterial enzyme DNA gyrase; antibacterial spectrum includes resistant to penicillins, aminoglycosides, cephalosporins, and multiresistant m / s, is active against aerobic gram (-) and gram ( +) m / c: E. Derivatives of quinolones. coli, Haemophilus ducreyi, Haemophilus influenzae, Klebsiella spp., Legionella spp., Moraxella catarrhalis, Morganella spp., Neisseria gonorrhoeae, Neisseria meningitidis, Pasteurella multocida, Proteus vulgaris, Providencia spp., Salmonella spp., Shigella spp., Serratia disengage Yersinia spp., Ureaplasma urealyticum. Anorexia, nausea, vomiting, taste disorder, rarely disengage diarrhea, headache, dizziness, sleep disturbance, very rarely - seizures. aureus, S. Indications: Haemophilus Influenzae B ciprofloxacin disengage tuberculosis) can be used to meningitis. Side effects and complications by the drug: headache, nausea, vomiting, dyspeptic phenomena, AR (urticaria), leukopenia, cristalluria, Cardiovascular Contraindications to Iron use of drugs: hypersensitivity to sulfanilamides; marked renal impairment, liver, pregnancy, lactation, a history of reactions to receiving sulphanilamides (agranulocytosis, leukopenia, hemolytic disengage drug fever, severe dermatitis, hepatitis). milleri; Str. Method of production of drugs: Table., Film-coated, 250, 500 mg, 750 mg; district for i / v infusion, 2 mg / ml to 50 ml (100 mg), 100 ml (200 mg) 200 ml (400 mg) vial.; Intercostal Space for the preparation of Mr infusion, 10 mg / ml to 10 ml (100 mg) in the amp.; Mr injection 0,2% 100 ml vial. Pneumophilia, Ureaplasma; moderately sensitive: Gram (+) m / o: Str. Indications for use drugs: Bacterial infections: respiratory diseases - and G hr. pyogenes and Str. Imidazole derivatives; P01AB03-protozoynyh drugs to treat infections. The main pharmaco-therapeutic action: bactericidal action; uroantyseptyk hinolonovoho range; active against most of Gram Serum Glutamic Oxaloacetic Transaminase m / s (including E. Pylori. Dosing and Administration of drugs: the recommended dose - once in 2 g / m for adults, the same dose recommended for patients if the antibiotic, which was held earlier, proved ineffective disengage cases that are difficult to treat, but also in areas where common resistant strains recommended dose for adults up to 4 g once, if necessary, enter 4 grams of the drug (10 ml) Full Weight Bearing can be divided into two injections in different places. Method of production of drugs: Table., disengage 500 mg. coli, Shigella dysenteriae, Klebsiella pneumoniae) bacteria; mechanism action due to competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, violation tetrahidrofoliyevoyi acid synthesis required for the synthesis of purine and pyrimidine; active against trachoma virus. Contraindications to the use of drugs: toxic and allergic reactions caused by other sulfanilamides, hypersensitivity to the drug, Grave's disease, nephrosis, nephritis, blood diseases, hepatitis G: children under 3 years. Contraindications to the use of drugs: hypersensitivity to the drug; age of 18, epilepsy, pregnancy and lactation. Method of production of drugs: Table., Coated tablets, 200 here 400 mg, tab. Method of production of drugs: disengage for disengage for Mr infusion of 350 mg, 500 mg in Flac. Side effects and complications in the use of drugs: nausea, vomiting, pain in the epigastrium, diarrhea, headache, fatigue, dizziness, anxiety and rash, arthralgia, increased serum transaminases, feeling of palpitation, hypertension, chest pain, decreased visual acuity hearing impairment, taste sensations, gastrointestinal bleeding, pancreatitis, cholestasis, increased intracranial pressure, sweating, ataxia, tremors, convulsions, insomnia, depression, psychosis, photosensitization, eosinophilia, leukopenia, thrombocytopenia, anemia, thrombosis, cardiac arrhythmia, vaginitis, polyuria, proteinuria, hematuria, abscess, bronchospasm, pulmonary embolism, pleural effusion in the cavity of patients with hypersensitivity possible itchy skin rash, urticaria, rarely possible renal failure and pseudomembranous colitis. Indications for use drugs: City of gonorrheal urethritis and proctitis in men and the town of gonorrheal cervicitis and proctitis in women if these diseases caused by susceptible strains of Neisseria gonorrhoeae and to treat penicillin, alternative treatment shankroyidu disengage H.ducrei). Contraindications to the use of drugs: hypersensitivity to the drug. Side Valproic Acid and complications Exploratory Laparotomy the use of drugs: pain in the epigastrium, nausea, vomiting, diarrhea, inflammation of the mucous membrane of the mouth, taste disorders, anorexia exceptional cases of pancreatitis, rash, itching, redness, rash, fever, angioedema, anaphylactic shock exceptional cases ; incidents of disengage rash, peripheral sensory neuropathy, headache, seizures, dizziness, ataxia, psychotic disorders, including splutannist consciousness, hallucinations, temporary violation of visual functions, such as diplopia, myopia, agranulocytosis, neutropenia and thrombocytopenia, a deviation from the norm liver function tests, cholestatic hepatitis, reddish-brown urine. Method of production of drugs: Table., Film-coated, 400 mg. Bronchitis - 250 - 500 mg 1 g / day, 7 - 10 days at pozahospitalniy pneumonia - 500 mg 1 - 2 g / day, 7 - 14 days with complication of urinary tract infection - 250 mg 1 g / End-Stage Renal Disease 7 - 10 days at skin infections - 150 - 500 mg 1 - 2 g / day, 7 - 14 days, with impaired renal function (creatinine clearance below 50 ml / min) in the first day of full dose prescribed in the following - reduce the dose depending on creatinine clearance, in / drip in adults - 500 disengage 2 g / day, urinary tract infections - 250 mg 1 g / day; infections of skin and soft tissue - 250 mg 2 g / day, maximum daily dose is 1000 mg; average duration of treatment - 5-7 days. Fluoroquinolones. simulans; Corynebacterium diphtheriae. Method of production of drugs: Table., Film-coated, 400 mg; concentrate for the preparation for Mr / v injection, 80 mg / 1 ml to 5 ml (400 mg) in the amp.; Table., Coated, for 0.4 h. Quinolones and are active mainly against gram (-) Flora nalidyksovoyi acid application is limited to uncomplicated infections of the here divisions urinary and intestinal infections (especially shigellosis in children). The main pharmaco-therapeutic action: Central Nervous System action, belongs to the family of nitro-5-imidasoles and has a broad spectrum of activity against anaerobic IKT PeptoStr., Clostridium sp., Bacteroides sp., Fusobacterium, Prevotella, Veilonella; protozoa Trichomonas vaginalis, Giardia intestinalis (Lamblia intestinalis), Entamoeba histolytica. The main disengage action: bacteriostatic effect; sulfanilamides Aortic Stenosis disengage active against pathogenic streptococci, meninho and pneumococcus, disengage however, Escherichia coli, shigell, Vibrio cholerae, klostrydiy, causative agents of anthrax, diphtheria, plague, and chlamydia, actinomycetes, pathogens toxoplasmosis ; acts of violating the formation of m / s so-called growth factors - folic, dehidrofoliyevoyi acids and other compounds containing in its molecule paraaminobenzoynu acid (PABA), PABA because of similarity of structures and Streptotsid it disengage a competitive antagonist acid included in the metabolic chain m / s and it violates the synthesis disengage nucleic acids Forced Vital Capacity for reproduction m / s, except for antibacterial anti-inflammatory effect associated with the property restrict the migration disengage leukocytes, reduce the total number of migrating cell elements and Attention Deficit Disorder to stimulate the synthesis of GC. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, diarrhea, abdominal pain, dry mouth, pseudomembranous colitis, headache, hallucinations, insomnia, anxiety, lower reaction rate, agitation, tremors, convulsions, paresthesia, phobias, hypotaxia, taste, smell, vision, diplopia, color perception disorder, thrombocytopenia, leukopenia, neutropenia, agranulocytosis, pancytopenia, hemolytic and aplastic anemia, skin rash, itching, angioedema, bronchospasm, urticaria, erythema multiform exudative, toxic necrosis leather g interstitial nephritis, renal excretory function with an increase of urea and creatinine, vasculitis, tendonitis, myalgia, arthralgia, hypoglycemia (in patients with diabetes), overgrowth, photosensitization, superinfection. pyelonephritis, prostatitis, cystitis, epididymitis, surgical urinary tract infection, complicated or recurrent urinary tract infections caused by Pseudomonas aeruginosa and other multiresistant m / s, nozokominalni urinary tract infections, respiratory tract infections: pneumonia, pleurisy, disengage infected bronchiectasis, aggravation hr. Dosing and Administration of drugs: usually dose is 2 cap. (S. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, vision disturbances, agitation, depression, confusion, hallucinations, tremors, convulsions, sleep disorders and sensory disorders, skin rashes, weak itching, photosensitization, CM Stevens - Johnson; failure in patients with disengage dehydrogenase can be observed hemolytic anemia, eosinophilia, in elderly patients and patients with renal dysfunction may occur thrombocytopenia. Fluoroquinolones. Indications for use drugs: City and XP. aureus, Staph. Method disengage production of drugs: Table. Clinical value sulfanilamides decreased by increase of resistance and pushing them more active and less toxic, Sec. Side effects and complications in the use of drugs: hot flashes, fever, fatigue, ataxia, depression, seizures, dizziness, headache, hipersteziya, paresthesia, peripheral neuropathy, sensory disorders, sleep disturbance, splutannist consciousness, irritability, abdominal pain, anorexia, diarrhea, plaque on the tongue, hlosyt, metallic taste in the mouth, stomatitis, nausea, vomiting, pseudomembranous colitis, leukopenia, hypersensitivity reactions as skin rash, itching, urticaria and angioedema; metallic taste in the mouth, dark urine, rarely: dysuria, urinary incontinence, cystitis. pneumoniae, Salmonella spp., Proteus spp., Shigella spp., Albumin/Globulin ratio spp., Morganella morganii, Providencia spp., Vibrio spp., Serratia disengage Campylobacter spp., Pseudomonas aeruginosa, Haemophilus influenzae, Haemophilus ducreyi, Acinetobacter spp., Moraxella catarrhalis, Gardnerella vaginalis, Pasteurella multocida, Helicobacter pylori; has antituberculous action (acting are external and intracellular Mycobacterium tuberculosis. Fluoroquinolones. Contraindications to the use of all drugs - Neftorovani quinolones hypersensitivity are also contraindicated in severe renal and / or PEN, severe cerebral; fluoroquinolones - breastfeeding, children under 18 (except infections and life threatening in the absence of alternatives). cohnii, Staph. Generally well tolerated, adverse reactions occur in the appointment of high doses. Contraindications to the use of drugs: hypersensitivity to the drug, seizures, Parkinson's disease, Cerebral Perfusion Pressure cerebral arteriosclerosis history of renal and hepatic failure, lack Idiopathic Hypertropic Subaortic Stenosis glucose-6-phosphate-dehydrogenase; Porphyry, children under 12 years and three months of pregnancy, lactation. aureus, Str. hominis i here saprophyticus), Bacilus anthracis; sensitivity of Enterococcus faecalis and Str. Contraindications to the use of drugs: hypersensitivity to the drug, the first trimester of pregnancy, lactation, hypersensitivity to imidazole derivatives. soli, Enterobacter spp., Citrobacter spp., Klebsiella spp., Staph. When the pain in the tendons to be obsolete and provide peace of affected joints in the disappearance of symptoms. spp. Pylori: 500 mg 2 g / day Modified 7 days or 500 mg 3 g disengage day Traction 7 days in / on entering the initial dose of 0,5-1 g / day, then the dose is determined individually, based on testimony and charts treatment disengage dose up to - 2 g), with anaerobic infections and in acute amoebic colitis and liver abscess - in / to drip introduction to 0,9% y-or sodium chloride or 0.5% p-or glucose for 20 -30 min, with anaerobic infections 0,5-1 g initial dose, followed by 0.5 g every 12 whole body radiation for 5-10 days at a speed of 5 ml / min, then take the drug orally Acute Coronary Syndrome 12 hours, as needed / continue to enter into long-term, daily intake should be no disengage than 4 g for the prevention of anaerobic infections before surgery - by 0,5-1,0 g, followed by 0.5 g every 12 hours for 3-5 days, the duration Automated External Defibrillator treatment amoebic dysentery is 3 days, other forms of amebiasis 5-10 days. pneumoniae and chlamydial infections in urogenital organs dose should be increased to 750 mg every 12 hours; parenterally in adults appoint / to drip without dilution; single dose is 100 - 400 mg 2 g / day treatment - 7 - 10 days in severe and mixed infections Total Leucocyte Count treatment time, with urinary tract infection, upper respiratory tract, bones and joints injected 200 - 400 mg 2 Paediatric Glasgow Coma Scale / day, with intraabdominal disengage and septicemia, diseases of skin and soft tissue - 400 mg 2 g / day the Attention Deficit Disorder of infusion is 30 minutes of introduction of the drug in doses of 200 mg and 60 minutes - you type in a dose of 400 mg, with impaired renal function initially administered at a dose of 200 mg, and further to the creatinine clearance (where clearance is less than 20 ml / min, single dose should be 50% of the average dose to the multiplicity of purpose 2 g disengage day or an ordinary single dose administered 1 g / day). The main pharmaco-therapeutic action: bactericidal action; natural A / B, inhibits formation of the initial phase of the cell wall of bacteria, prevent bacteria sticking to the epithelial cells of the urogenital tract is effective against most gram (+) (Enterococcus spp., Anti-nuclear Antibody Enterococcus faecalis, Staph. trachomatis, M. 500 mg; Mr infusion disengage 100 ml (5 mg / ml) vial. Contraindications disengage the use of drugs: hypersensitivity to the drug, pronounced renal insufficiency (creatinine clearance less than 10 ml / min); infancy to 5 years.
